Lv4
610 积分 2023-09-20 加入
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study
5个月前
已完结
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
5个月前
已完结
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
5个月前
已完结
Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation
5个月前
已完结
Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study
5个月前
已完结
Open‐label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non‐myeloid malignancies
5个月前
已完结
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
5个月前
已完结
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis
5个月前
已完结
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
5个月前
已完结
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
5个月前
已完结
皖公网安备34019202002308
